BiotechTube
Home/Rejuvenation Technologies/Daniel Chambers
DC

Daniel Chambers

Chief Medical Officer (Part-time)

Rejuvenation Technologies

Therapeutic Areas

Pulmonary FibrosisChronic Liver DiseaseHematologic DiseasesAging

Rejuvenation Technologies Pipeline

DrugIndicationPhase
TeloAT2Pulmonary FibrosisPhase 1
TeloHepChronic Liver DiseasePhase 1
TeloHSCHematologic IndicationPhase 1

Leadership Team at Rejuvenation Technologies

JR
John Ramunas
Founder & CEO
GM
Glenn Markov
Founder & COO
BF
Bob Fishman
Director of Clinical Development
View full Rejuvenation Technologies profile